Association of the rs738409 polymorphism in <it>PNPLA3 </it>with liver damage and the development of nonalcoholic fatty liver disease

<p>Abstract</p> <p>Background</p> <p>In a genome-wide association scan, the single-nucleotide polymorphism (SNP) rs738409 in the patatin-like phospholipase 3 gene (<it>PNPLA3</it>) was strongly associated with increased liver fat content. We investigated whe...

Full description

Saved in:
Bibliographic Details
Main Authors: Chayama Kazuaki (Author), Mizusawa Seiho (Author), Ueno Takato (Author), Ochi Hidenori (Author), Hyogo Hideyuki (Author), Yoneda Masato (Author), Hotta Kikuko (Author), Nakajima Atsushi (Author), Nakao Kazuwa (Author), Sekine Akihiro (Author)
Format: Book
Published: BMC, 2010-12-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_cde7eb49c6fb4cba9f1c61548438c1a2
042 |a dc 
100 1 0 |a Chayama Kazuaki  |e author 
700 1 0 |a Mizusawa Seiho  |e author 
700 1 0 |a Ueno Takato  |e author 
700 1 0 |a Ochi Hidenori  |e author 
700 1 0 |a Hyogo Hideyuki  |e author 
700 1 0 |a Yoneda Masato  |e author 
700 1 0 |a Hotta Kikuko  |e author 
700 1 0 |a Nakajima Atsushi  |e author 
700 1 0 |a Nakao Kazuwa  |e author 
700 1 0 |a Sekine Akihiro  |e author 
245 0 0 |a Association of the rs738409 polymorphism in <it>PNPLA3 </it>with liver damage and the development of nonalcoholic fatty liver disease 
260 |b BMC,   |c 2010-12-01T00:00:00Z. 
500 |a 10.1186/1471-2350-11-172 
500 |a 1471-2350 
520 |a <p>Abstract</p> <p>Background</p> <p>In a genome-wide association scan, the single-nucleotide polymorphism (SNP) rs738409 in the patatin-like phospholipase 3 gene (<it>PNPLA3</it>) was strongly associated with increased liver fat content. We investigated whether this SNP is associated with the occurrence and progression of nonalcoholic fatty liver disease (NAFLD) in the Japanese population.</p> <p>Methods</p> <p>SNP rs738409 was genotyped by the Taqman assay in 253 patients with NAFLD (189 with nonalcoholic steatohepatitis [NASH] and 64 with simple steatosis) and 578 control subjects. All patients with NAFLD underwent liver biopsy. Control subjects had no metabolic disorders. For a case-control study, the <it>χ</it><sup>2</sup>-test (additive model) was performed. Odds ratios (ORs) were adjusted for age, gender, and body mass index (BMI) by using multiple logistic regression analysis with genotypes (additive model), age, gender, and BMI as the independent variables. Multiple linear regression analysis was performed to test the independent effect of risk allele on clinical parameters while considering the effects of other variables (age, gender, and BMI), which were assumed to be independent of the effect of the SNP.</p> <p>Results</p> <p>The risk allele (G-allele) frequency of rs738409 was 0.44 in the control subjects and 0.60 in patients with NAFLD; this shows a strong association with NAFLD (additive model, <it>P </it>= 9.4 × 10<sup>-10</sup>). The OR (95% confidence interval) adjusted for age, gender, and BMI was 1.73 (1.25-2.38). Multiple linear regression analysis indicated that the G-allele of rs738409 was significantly associated with increases in aspartate transaminase (AST) (<it>P </it>= 0.00013), alanine transaminase (ALT) (<it>P </it>= 9.1 × 10<sup>-6</sup>), and ferritin levels (<it>P </it>= 0.014), and the fibrosis stage (<it>P </it>= 0.011) in the patients with NAFLD, even after adjustment for age, gender, and BMI. The steatosis grade was not associated with rs738409.</p> <p>Conclusions</p> <p>We found that in the Japanese population, individuals harboring the G-allele of rs738409 were susceptible to NAFLD, and that rs738409 was associated with plasma levels of ALT, AST, and ferritin, and the histological fibrosis stage. Our study suggests that <it>PNPLA3 </it>may be involved in the progression of fibrosis in NAFLD.</p> 
546 |a EN 
690 |a Internal medicine 
690 |a RC31-1245 
690 |a Genetics 
690 |a QH426-470 
655 7 |a article  |2 local 
786 0 |n BMC Medical Genetics, Vol 11, Iss 1, p 172 (2010) 
787 0 |n http://www.biomedcentral.com/1471-2350/11/172 
787 0 |n https://doaj.org/toc/1471-2350 
856 4 1 |u https://doaj.org/article/cde7eb49c6fb4cba9f1c61548438c1a2  |z Connect to this object online.